What happened with RYM today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
RYTHM, Inc. sells drinks and edibles containing hemp-derived THC. These include RYTHM and Señorita beverages and incredibles and Beboe edibles. Third-party manufacturers make the products in the United States and Canada, and consumers and retailers buy them through online sales and retail channels. Product sales provide the larger share of revenue, while brand licensing contributes a substantial portion.
The licensing business depends entirely on Green Thumb, whose subsidiary GTI Core pays monthly cash fees to use brands including incredibles, RYTHM and Beboe in its state-licensed cannabis businesses. RYTHM does not operate those businesses itself and depends on the licensee’s ability to keep selling. Green Thumb also supplies significant legal, accounting and operational support.
Legal access to the market is central to both businesses. State rules restrict where and how hemp products can be sold, and the FDA considers THC-containing foods and beverages impermissible under federal food and drug law. RYTHM says a federal hemp-law amendment would prevent sales of its current hemp-derived THC products beginning November 12, 2026, unless changed or delayed. Taking effect would also meet one condition allowing Green Thumb or its affiliates to repurchase acquired brand assets, potentially removing a material licensing revenue source; exercising that right is optional.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
RYTHM’s results hinge on brand-license payments from Green Thumb’s GTI Core subsidiary and whether federal law allows it to keep selling hemp-derived THC products.
cbdMD competes with RYTHM for consumers buying hemp-derived THC drinks and other cannabinoid products online and through retailers. Watch cbdMD’s online sales—the channel accounted for approximately 77% of its fiscal 2025 sales—as a read on demand in a channel RYTHM also uses for its drinks and edibles.
RYTHM, Inc. earningsThis company
RYTHM, Inc. sells hemp-derived cannabinoid products and collects brand fees from licensees such as Green Thumb, and this report will show how much each supports the business.
Read hemp-derived product sales alongside licensing revenue, and note how much licensing still comes from related parties. Steady licensing with support from product sales would show brand fees are becoming a more dependable revenue base; weaker licensing, especially alongside falling product sales, would show the business still depends on licensee sales while its own products face the federal restriction.
cbdMD, Inc. earningsYCBD
cbdMD, Inc. reports results from a business that sells mostly online, offering a read on demand for cannabinoid products in a channel RYTHM, Inc. also uses.
Check whether cbdMD’s online sales rise and compare that with its overall sales. Growth online would show consumers are still buying cannabinoid products through a channel RYTHM also uses; a decline would point to pressure in that channel, but would not establish how RYTHM’s own sales changed.
